title: MCF7, 2-Hexyldecanoic acid_5uM, rep4, P04 [PGD201-P04]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-P04


title: MCF7, 2-Hexyldecanoic acid_5uM, rep2, I06 [PGD201-I06]

status: Public on Nov 01 2024

type: RNA

city: Mason

first: Yuqing

last: Shan

state: Ohio

address: 8700 mason montgomery road

country: USA

institute: Procter & Gamble

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-I06

hyb_protocol: PCR amplicon of each gene is hybridized to barcoded Luminex beads. The barcode incorporated in each amplicon is complementary to a barcode on a Luminex bead, ensuring that each gene from the original lysate mRNA is represented by an amplicon bound to a specific bead.

scan_protocol: Luminex scanners detect individual beads by color, then measure the fluorescent intensity of the SAPE molecules attached to the biotin label on each amplicon-bound bead

data_processing: Raw intensity measurements are deconvoluted to provide intensity values for each landmark gene (the 978 directly measured features). Data is then normalized using a calibration curve based on invariant gene sets, and then quantile normalized.

label: biotin

molecule: total RNA

organism: Homo sapiens

label_protocol: mRNA is reverse transcribed and the cDNA product PCR amplified using primers that contain contiguous sequence (barcode) complementary to each L1000 gene; in addition, the upstream primer is biotinylated to enable identification of amplicon-bound beads.

growth_protocol: MCF7, A549 and HepG2 cells were grown in phenol red free DMEM, supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin. The iCardiomyocyte cells were grown in a proprietary maintenance medium (FujiFilm Cellular Dynamics, Inc.) for 168 h before chemical treatment. All cells were maintained at 37°C in an atmosphere of 5% CO2.

extract_protocol: Cells were lysed with cell lysis buffer (100 µL per well), and stored at -80⁰C

treatment_protocol: Cells were treated with compounds for 6h at 37oC in an atmosphere of 5% CO2

tag: cell type

value: human breast adenocarcinoma


title: MCF7, 2-Hexyldecanoic acid_50uM, rep4, F04 [PGD201-F04]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-F04


title: MCF7, 2-Ethylbutanoic acid_50uM, rep1, A17 [PGD201-A17]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-A17


title: MCF7, 2-Hexyldecanoic acid_50uM, rep1, C09 [PGD201-C09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-C09


title: MCF7, 2-Hexyldecanoic acid_500uM, rep4, D06 [PGD201-D06]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-D06


title: MCF7, 2-Hexyldecanoic acid_500uM, rep1, E19 [PGD201-E19]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-E19


title: MCF7, 2-Hexyldecanoic acid_50uM, rep3, B11 [PGD201-B11]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-B11


title: MCF7, 2-Propylnonanoic acid_500uM, rep1, K05 [PGD201-K05]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-K05


title: MCF7, 2-Propylnonanoic acid_5uM, rep1, I01 [PGD201-I01]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-I01


title: MCF7, 2-Propylnonanoic acid_50uM, rep2, I16 [PGD201-I16]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-I16


title: MCF7, 2-Hexyldecanoic acid_500uM, rep2, A14 [PGD201-A14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-A14


title: MCF7, 2-Propylnonanoic acid_5uM, rep4, N14 [PGD201-N14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-N14


title: MCF7, 2-Propylnonanoic acid_50uM, rep4, P18 [PGD201-P18]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-P18


title: MCF7, 2-Propylnonanoic acid_50uM, rep1, A09 [PGD201-A09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-A09


title: MCF7, 2-Propylnonanoic acid_500uM, rep2, I08 [PGD201-I08]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-I08


title: MCF7, 2-Propylnonanoic acid_500uM, rep4, D18 [PGD201-D18]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-D18


title: MCF7, DMSO, rep2, O16 [PGD201-O16]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-O16


title: MCF7, DMSO, rep4, P16 [PGD201-P16]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-P16


title: MCF7, 2-Propylnonanoic acid_5uM, rep3, H13 [PGD201-H13]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-H13


title: MCF7, 2-Propylnonanoic acid_50uM, rep3, H21 [PGD201-H21]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-H21


title: MCF7, DMSO, rep2, M08 [PGD201-M08]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-M08


title: MCF7, DMSO, rep3, P15 [PGD201-P15]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-P15


title: MCF7, DMSO, rep3, L01 [PGD201-L01]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-L01


title: MCF7, DMSO, rep1, O15 [PGD201-O15]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-O15


title: MCF7, 2-Propylnonanoic acid_500uM, rep3, N09 [PGD201-N09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-N09


title: MCF7, DMSO, rep3, N07 [PGD201-N07]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-N07


title: MCF7, DMSO, rep4, L02 [PGD201-L02]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-L02


title: MCF7, DMSO, rep1, K17 [PGD201-K17]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-K17


title: MCF7, DMSO, rep1, M07 [PGD201-M07]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-M07


title: MCF7, DMSO, rep4, N08 [PGD201-N08]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-N08


title: MCF7, DMSO, rep2, K02 [PGD201-K02]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-K02


title: MCF7, DMSO, rep3, L17 [PGD201-L17]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-L17


title: MCF7, DMSO, rep4, J10 [PGD201-J10]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-J10


title: MCF7, DMSO, rep3, J09 [PGD201-J09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-J09


title: MCF7, DMSO, rep1, I09 [PGD201-I09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-I09


title: MCF7, DMSO, rep3, H03 [PGD201-H03]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-H03


title: MCF7, DMSO, rep2, G20 [PGD201-G20]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-G20


title: MCF7, 2-Propylnonanoic acid_5uM, rep2, E12 [PGD201-E12]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-E12


title: MCF7, DMSO, rep4, H20 [PGD201-H20]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-H20


title: MCF7, DMSO, rep3, H19 [PGD201-H19]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-H19


title: MCF7, DMSO, rep1, G03 [PGD201-G03]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-G03


title: MCF7, DMSO, rep2, E14 [PGD201-E14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-E14


title: MCF7, DMSO, rep1, G19 [PGD201-G19]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-G19


title: MCF7, DMSO, rep2, I10 [PGD201-I10]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-I10


title: MCF7, DMSO, rep2, C24 [PGD201-C24]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-C24


title: MCF7, DMSO, rep2, G04 [PGD201-G04]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-G04


title: MCF7, DMSO, rep4, H04 [PGD201-H04]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-H04


title: MCF7, DMSO, rep3, D11 [PGD201-D11]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-D11


title: MCF7, DMSO, rep3, F13 [PGD201-F13]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-F13


title: MCF7, DMSO, rep3, D23 [PGD201-D23]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-D23


title: MCF7, DMSO, rep4, D12 [PGD201-D12]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-D12


title: MCF7, DMSO, rep1, E13 [PGD201-E13]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-E13


title: MCF7, DMSO, rep2, C12 [PGD201-C12]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-C12


title: MCF7, DMSO, rep4, F14 [PGD201-F14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-F14


title: MCF7, DMSO, rep4, B06 [PGD201-B06]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-B06


title: MCF7, DMSO, rep1, C11 [PGD201-C11]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-C11


title: MCF7, DMSO, rep3, B05 [PGD201-B05]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-B05


title: MCF7, DMSO, rep4, D24 [PGD201-D24]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-D24


title: MCF7, DMSO, rep2, A22 [PGD201-A22]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-A22


title: MCF7, DMSO, rep1, A21 [PGD201-A21]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-A21


title: MCF7, DMSO, rep2, A06 [PGD201-A06]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-A06


title: MCF7, DMSO, rep1, A05 [PGD201-A05]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-A05


title: MCF7, Octanoic acid_100, rep3, O01 [PGA801-O01]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-O01


title: iCAR, Octanoic acid_100, rep1, L06 [PGA801-L06]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-L06

source_name: iCell Cardiomyocytes²

value: Cardiomyocytes


title: iCAR, Octanoic acid_100, rep3, P02 [PGA801-P02]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-P02


title: MCF7, DMSO, rep4, B22 [PGD201-B22]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-B22


title: MCF7, DMSO, rep1, C23 [PGD201-C23]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGD201-C23


title: iCAR, Octanoic acid_100, rep2, N22 [PGA801-N22]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-N22


title: MCF7, Octanoic acid_100, rep1, K05 [PGA801-K05]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-K05


title: MCF7, Octanoic acid_100, rep2, M21 [PGA801-M21]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-M21


title: A549, Octanoic acid_100, rep2, M22 [PGA801-M22]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-M22


title: iCAR, Octanoic acid_250, rep1, D10 [PGA801-D10]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D10


title: HepG2, Octanoic acid_100, rep3, P01 [PGA801-P01]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-P01

value: human hepatocellular carcinoma


title: HepG2, Octanoic acid_100, rep2, N21 [PGA801-N21]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-N21


title: iCAR, Octanoic acid_250, rep2, D16 [PGA801-D16]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D16


title: MCF7, Octanoic acid_250, rep2, C15 [PGA801-C15]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C15


title: MCF7, Octanoic acid_250, rep1, C09 [PGA801-C09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C09


title: MCF7, Octanoic acid_250, rep3, I23 [PGA801-I23]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-I23


title: HepG2, Octanoic acid_100, rep1, L05 [PGA801-L05]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-L05


title: iCAR, Octanoic acid_250, rep3, J24 [PGA801-J24]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-J24


title: A549, Octanoic acid_250, rep3, I24 [PGA801-I24]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-I24


title: A549, Octanoic acid_100, rep3, O02 [PGA801-O02]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-O02


title: A549, Octanoic acid_250, rep1, C10 [PGA801-C10]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C10


title: A549, Octanoic acid_250, rep2, C16 [PGA801-C16]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C16


title: iCAR, Octanoic acid_500, rep3, F20 [PGA801-F20]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-F20


title: HepG2, Octanoic acid_250, rep2, D15 [PGA801-D15]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D15


title: iCAR, Octanoic acid_500, rep1, B14 [PGA801-B14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-B14


title: MCF7, Octanoic acid_500, rep1, A13 [PGA801-A13]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-A13


title: HepG2, Octanoic acid_250, rep1, D09 [PGA801-D09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D09


title: HepG2, Octanoic acid_250, rep3, J23 [PGA801-J23]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-J23


title: MCF7, Octanoic acid_500, rep3, E19 [PGA801-E19]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-E19


title: HepG2, Octanoic acid_500, rep2, F17 [PGA801-F17]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-F17


title: HepG2, Octanoic acid_500, rep3, F19 [PGA801-F19]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-F19


title: A549, Octanoic acid_500, rep3, E20 [PGA801-E20]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-E20


title: iCAR, Octanoic acid_500, rep2, F18 [PGA801-F18]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-F18


title: HepG2, Octanoic acid_500, rep1, B13 [PGA801-B13]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-B13


title: MCF7, Octanoic acid_500, rep2, E17 [PGA801-E17]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-E17


title: A549, Octanoic acid_500, rep2, E18 [PGA801-E18]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-E18


title: A549, Octanoic acid_500, rep1, A14 [PGA801-A14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-A14


title: iCAR, DMSO, rep3, P16 [PGA801-P16]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-P16


title: iCAR, DMSO, rep2, J10 [PGA801-J10]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-J10


title: iCAR, DMSO, rep3, N08 [PGA801-N08]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-N08


title: iCAR, DMSO, rep2, F14 [PGA801-F14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-F14


title: iCAR, DMSO, rep3, L02 [PGA801-L02]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-L02


title: iCAR, DMSO, rep2, H20 [PGA801-H20]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-H20


title: iCAR, DMSO, rep3, L18 [PGA801-L18]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-L18


title: iCAR, DMSO, rep1, B06 [PGA801-B06]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-B06


title: iCAR, DMSO, rep1, D24 [PGA801-D24]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D24


title: MCF7, DMSO, rep3, K17 [PGA801-K17]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-K17


title: MCF7, DMSO, rep3, O15 [PGA801-O15]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-O15


title: iCAR, DMSO, rep2, H04 [PGA801-H04]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-H04


title: iCAR, DMSO, rep1, B22 [PGA801-B22]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-B22


title: A549, Octanoic acid_100, rep1, K06 [PGA801-K06]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-K06


title: iCAR, DMSO, rep1, D12 [PGA801-D12]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D12


title: MCF7, DMSO, rep3, M07 [PGA801-M07]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-M07


title: MCF7, DMSO, rep2, G19 [PGA801-G19]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-G19


title: HepG2, DMSO, rep3, P15 [PGA801-P15]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-P15


title: MCF7, DMSO, rep2, I09 [PGA801-I09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-I09


title: MCF7, DMSO, rep2, G03 [PGA801-G03]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-G03


title: MCF7, DMSO, rep3, K01 [PGA801-K01]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-K01


title: MCF7, DMSO, rep1, C11 [PGA801-C11]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C11


title: MCF7, DMSO, rep1, C23 [PGA801-C23]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C23


title: MCF7, DMSO, rep1, A21 [PGA801-A21]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-A21


title: MCF7, DMSO, rep1, A05 [PGA801-A05]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-A05


title: HepG2, DMSO, rep3, N07 [PGA801-N07]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-N07


title: MCF7, DMSO, rep2, E13 [PGA801-E13]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-E13


title: HepG2, DMSO, rep3, L01 [PGA801-L01]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-L01


title: HepG2, DMSO, rep3, L17 [PGA801-L17]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-L17


title: HepG2, DMSO, rep2, J09 [PGA801-J09]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-J09


title: HepG2, DMSO, rep1, D23 [PGA801-D23]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D23


title: HepG2, DMSO, rep2, H03 [PGA801-H03]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-H03


title: HepG2, DMSO, rep1, D11 [PGA801-D11]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-D11


title: HepG2, DMSO, rep2, F13 [PGA801-F13]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-F13


title: HepG2, DMSO, rep2, H19 [PGA801-H19]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-H19


title: A549, DMSO, rep3, O16 [PGA801-O16]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-O16


title: A549, DMSO, rep3, M08 [PGA801-M08]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-M08


title: A549, DMSO, rep2, E14 [PGA801-E14]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-E14


title: S131

type: SRA

city: Davis

first: Barbara

last: Blanco-Ulate

state: California

address: One Shields Ave

department: Plant Sciences

institute: University of California Davis

library_source: transcriptomic

data_processing:
Quality and adapter trimming were done with Trimmomatic 0.33 with the parameters ILLUMINACLIP:TruSeq3-PE-2.fa:2:30:10 LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 MINLEN:36
Bowtie2 2.3.4 was used to map the reads to a combined transcriptome of Rhizopus stolonifer and each of the fruit hosts with the following options: --end-to-end --sensitive --no-unal -q -t -p 20
Read counts were extracted form the Bowtie2 alignments using the script sam2counts.py v.0.91
Assembly: Rhizopus stolonifer BLUCD01v1, Solanum licopersicum build SL4.0 with ITAG 4.0 annotations, Vitis vinifera PN40024, Fragaria x ananassa Camarosa v1.0.a1, Prunus salicina Zhongli No. 6 v1.0
Supplementary files format and content: Processed data file contains read counts per sample, with each sample being listed on one column from column B-AZ, and transcript IDs being listed on column A
Supplementary files format and content: -

organism: Vitis vinifera

source_name: Grape

extract_protocol:
RNA was extracted from 1 g of ground tissue as described in Blanco-Ulate et al. (2013). Culture media-grown samples and resulting libraries were obtained from Petrasch et al. (2019) (GEO accession GSE122555).
Libraries were prepared using the Illumina TruSeq RNA Sample Preparation Kit v2 (Illumina, CA).

tag: tissue

value: Grape

tag: agent

value: Rhizopus stolonifer

tag: time point

value: (hours_post_inoculation)  48


title: S128

value: (hours_post_inoculation)  24


title: S130


title: A549, DMSO, rep3, K18 [PGA801-K18]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-K18


title: A549, DMSO, rep2, G20 [PGA801-G20]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-G20


title: A549, DMSO, rep1, C24 [PGA801-C24]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C24


title: S127


title: S122

value: (hours_post_inoculation)  6


title: S123

value: (hours_post_inoculation)  12


title: A549, DMSO, rep1, C12 [PGA801-C12]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-C12


title: S124


title: S126


title: A549, DMSO, rep1, A22 [PGA801-A22]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-A22


title: A549, DMSO, rep1, A06 [PGA801-A06]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-A06


title: S120


title: HepG2, DMSO, rep1, B05 [PGA801-B05]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-B05


title: s_455_rep2

city: Columbia

first: Ramji

middle: Kumar

last: Bhandari

state: MO

address: 1200 University Avenue Lefevre Hall 114

department: Biological Sciences

institute: University of Missouri

description: s_455_bismairk_bt2.chromosome.bismark.cov.gz

library_source: genomic

data_processing:
Bismark (Version: v0.19.0) was used to map bisulfite sequencing reads onto medaka genome (Ensembl release-95) with default parameters (Krueger and Andrews, 2011). Tec To guarantee getting the most accurate mapping result, we only retained the reads being mapped on unique position of genome.  Technical replicates were merged together using the Samtools software. The utility “bismark_methylation_extractor” wrapped in Bismark was used to extract methylation levels on each site.
Genome_build: Ensembl release-95
Supplementary_files_format_and_content: bismark.cov

molecule: genomic DNA

organism: Oryzias latipes

source_name: Unfertilized egg

growth_protocol: The medaka strain Hd-rR was used and maintained under standard conditions

extract_protocol:
Genomic DNA and total RNA from each embryo samples were extracted using AllPrep DNA/RNA/miRNA Universal Kit (QIAGEN, Cat No.: 80224) according to the manufacturer’s instruction.
Whole genome bisulfite sequencing (WGBS) libraries were prepared with NEBNext® Ultra™ II FS DNA Library Prep Kit (NEB, E7805S) according to the manufacturer’s user manual.

tag: strain

value: Hd-rR

tag: genotype

value: Wildtype


title: S129


title: s_320_rep2

description: s_320_bismairk_bt2.chromosome.bismark.cov.gz


title: s_529_rep2

description: s_529_bismairk_bt2.chromosome.bismark.cov.gz


title: s_529_rep1


title: A549, DMSO, rep2, I10 [PGA801-I10]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-I10


title: s_455_rep1


title: S125


title: S121


title: s_320_rep1


title: HIV Positive without Cervical Cancer [LCX0049]

type: genomic

city: Chicago

first: Yinan

last: Zheng

state: Illinois

address: 680 N Lake Shore Drive, Suite 1400

department: Department of Preventive Medicine

institute: Northwestern University

description: HIV Positive without Cervical Cancer

hyb_protocol: Bisulphite converted DNA was samplified, fragmented and hybridized to human infinium MethylationEPIC BeadChip (illumina) using standard illumina protocol

scan_protocol: Arrays were imaged using BeadArray Reader (HiScan) and standard recommended illumina scanner setting

data_processing: ENmix package in R environment (v4.4.0)

label: Cy3 and Cy5

source_name: cervical tissue

label_protocol: Standard illumina Protocol

extract_protocol: DNA extraction was carried out on cervical tissue biopsies using QIAGEN QIAamp DNA Mini Kit

tag: participant id

tag: Sex

value: Female

tag: cancer stage

tag: colposcopy based dysplasia grade

tag: group

value: cervical tissue

tag: hpv genotype

tag: age

tag: bmi

tag: site

value: LUTH


title: HIV Positive without Cervical Cancer [LCX0050]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO048]

description: HIV Positive without Cervical Cancer


title: A549, DMSO, rep2, K02 [PGA801-K02]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-K02


title: HepG2, DMSO, rep1, B21 [PGA801-B21]

description:
4 cell lines were used and experiment were performed in 96-well plates . Each 96-well plate included: A1 empty well, 12 vehicle wells, and 2 positive control wells (in duplicate) per cell line (i.e., per plate). The remaining 79 wells were used for test compounds: all 9 chemicals were tested at 3 doses and 4 reps except octanoic acid which had 3 replicates.
PGA801-B21


title: HIV Positive without Cervical Cancer [LCXO047]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO042]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO045]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO039]

description: HIV Positive without Cervical Cancer


title: HIV Positive Cervical Cancer [LCXO036]

description: HIV Positive Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO046]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO038]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO035]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO037]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO041]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO034]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO033]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO044]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO043]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO031]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO030]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO032]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO040]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO028]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO027]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO029]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0022]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0021]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO020]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0018]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO026]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0023]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0019]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO017]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0024]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0015]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0016]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0013]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0008]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0010]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0012]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0014]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0009]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0007]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0011]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0006]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO025]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0004]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0005]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCXO003]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [LCX0002]

description: HIV Positive without Cervical Cancer


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN048]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN048]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN047]

value: CIN 1


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN047]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN045]

value: CIN 2


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN036]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN039]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN035]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN039]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN034]

value: CIN 3


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN036]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN035]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN034]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN029]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN029]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN028]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN033]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN028]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN031]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN031]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN027]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN027]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN025]


title: HIV Positive without Cervical Cancer [LCXO001]

description: HIV Positive without Cervical Cancer


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN025]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN024]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN024]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN021]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN021]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN020]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN045]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN020]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN019]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN018]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN016]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN033]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN018]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN014]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN016]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN013]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN013]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN012]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN011]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN012]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN007]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN009]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN006]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN007]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN009]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN006]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN010]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN005]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN005]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN004]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX100]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN019]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN014]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX097]


title: HIV negative Cervical Cancer from tumor tissue [LCACX094]


title: HIV negative Cervical Cancer from tumor tissue [LCACX095]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX095]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN011]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX094]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX093]


title: HIV negative Cervical Cancer from tumor tissue [LCACX093]


title: HIV Positive with Cervical intraepithelial neoplasia from normal tissue [LCIN010]


title: HIV negative Cervical Cancer from tumor tissue [LCACX092]

value: III


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX091]

value: II


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX092]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX090]


title: HIV negative Cervical Cancer from tumor tissue [LCACX090]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX088]


title: HIV negative Cervical Cancer from tumor tissue [LCACX100]


title: HIV Positive Cervical Cancer from adjacent normal tissue [LCACX089]


title: HIV Positive Cervical Cancer from tumor tissue [LCACX089]


title: HIV Positive with Cervical intraepithelial neoplasia from abnormal tissue [LCIN004]


title: HIV negative Cervical Cancer from tumor tissue [LCACX086]


title: HIV negative Cervical Cancer from tumor tissue [LCACX088]


title: HIV negative Cervical Cancer from tumor tissue [LCACX083]


title: HIV negative Cervical Cancer [LCACX098]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX085]


title: HIV negative Cervical Cancer from tumor tissue [LCACX085]


title: HIV negative Cervical Cancer from tumor tissue [LCACX080]


title: HIV negative Cervical Cancer from tumor tissue [LCACX097]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX083]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX080]


title: HIV Positive Cervical Cancer from tumor tissue [LCACX077]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX079]


title: HIV negative Cervical Cancer from tumor tissue [LCACX071]

value: I


title: HIV negative Cervical Cancer from tumor tissue [LCACX079]


title: HIV Positive Cervical Cancer from adjacent normal tissue [LCACX077]


title: HIV negative Cervical Cancer from tumor tissue [LCACX091]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX073]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX071]


title: HIV negative Cervical Cancer from tumor tissue [LCACX073]


title: HIV negative Cervical Cancer from tumor tissue [LCACX069]


title: HIV negative Cervical Cancer from tumor tissue [LCACX067]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX067]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX068]

value: IV


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX086]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX066]


title: HIV negative Cervical Cancer from tumor tissue [LCACX066]


title: HIV Positive Cervical Cancer from adjacent normal tissue [LCACX065]


title: HIV Positive Cervical Cancer from tumor tissue [LCACX065]


title: HIV negative Cervical Cancer from tumor tissue [LCACX060]


title: HIV negative Cervical Cancer from tumor tissue [LCACX061]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX061]


title: HIV negative Cervical Cancer from tumor tissue [LCACX056]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX060]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX055]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX056]


title: HIV negative Cervical Cancer [LCACX054]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX052]


title: HIV negative Cervical Cancer from tumor tissue [LCACX052]


title: HIV negative Cervical Cancer from tumor tissue [LCACX051]


title: HIV negative Cervical Cancer from tumor tissue [LCACX055]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX051]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX049]


title: HIV negative Cervical Cancer from tumor tissue [LCACX049]


title: HIV negative Cervical Cancer from tumor tissue [LCACX048]


title: HIV negative Cervical Cancer from tumor tissue [LCACX068]


title: HIV Positive Cervical Cancer from tumor tissue [LCACX046]


title: HIV Positive Cervical Cancer from adjacent normal tissue [LCACX046]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX069]


title: HIV negative Cervical Cancer from tumor tissue [LCACX042]


title: HIV Positive Cervical Cancer from adjacent normal tissue [LCACX038]


title: HIV negative Cervical Cancer from tumor tissue [LCACX037]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX037]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX042]


title: HIV Positive Cervical Cancer from tumor tissue [LCACX038]


title: HIV negative Cervical Cancer from tumor tissue [LCACX036]


title: HIV negative Cervical Cancer from tumor tissue [LCACX034]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX036]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX034]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX033]


title: HIV negative Cervical Cancer from tumor tissue [LCACX032]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX029]


title: HIV negative Cervical Cancer from tumor tissue [LCACX033]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX032]


title: HIV negative Cervical Cancer from tumor tissue [LCACX029]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX048]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX027]


title: HIV negative Cervical Cancer from tumor tissue [LCACX027]


title: HIV negative Cervical Cancer from tumor tissue [LCACX025]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX025]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX026]


title: HIV negative Cervical Cancer from tumor tissue [LCACX024]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX024]


title: HIV negative Cervical Cancer from tumor tissue [LCACX023]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX043]


title: HIV negative Cervical Cancer from tumor tissue [LCACX043]


title: HIV negative Cervical Cancer from tumor tissue [LCACX021]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX021]


title: HIV negative Cervical Cancer from tumor tissue [LCACX022]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX022]


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX018]


title: HIV negative Cervical Cancer [LCACX019]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer from tumor tissue [LCACX018]


title: HIV negative Cervical Cancer [LCACX015]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer from tumor tissue [LCACX010]


title: HIV negative Cervical Cancer [LCACX009]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer [LCACX007]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX010]


title: HIV negative Cervical Cancer [LCACX008]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer [LCACX006]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer [LCACX004]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer [LCACX005]

description: HIV negative Cervical Cancer


title: HIV negative Cervical Cancer from tumor tissue [LCACX026]


title: HIV Positive without Cervical Cancer [JCXO049]

description: HIV Positive without Cervical Cancer

value: JUTH


title: HIV negative Cervical Cancer from adjacent normal tissue [LCACX023]


title: HIV Positive without Cervical Cancer [JCXO048]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO050]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO043]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO047]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO044]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO042]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO046]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO041]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO045]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO040]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO039]

description: HIV Positive without Cervical Cancer


title: HIV negative Cervical Cancer [LCACX012]

description: HIV negative Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO035]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO037]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO034]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO033]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO036]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO030]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO032]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO028]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO029]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO025]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO026]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO027]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO038]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO019]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO020]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO022]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO023]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO017]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO021]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO018]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO015]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO024]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO016]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO031]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO013]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO014]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO012]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO011]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCX0010]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO009]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO006]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO007]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO008]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO005]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO004]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO002]

description: HIV Positive without Cervical Cancer


title: HIV Positive without Cervical Cancer [JCXO003]

description: HIV Positive without Cervical Cancer


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN133]


title: HIV Positive without Cervical Cancer [JCXO001]

description: HIV Positive without Cervical Cancer


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN135]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN131]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN132]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN134]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN129]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN128]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN121]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN122]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN125]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN127]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN119]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN120]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN123]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN117]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN112]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN111]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN116]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN115]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN114]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN109]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN113]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN110]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN106]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN108]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN102]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN101]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN104]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN099]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN097]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN098]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN100]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN095]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN094]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN090]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN091]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN093]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN087]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN085]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN084]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN107]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN081]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN083]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN076]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN080]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN077]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN078]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN075]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN092]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN074]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN071]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN096]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN073]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN068]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN069]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN089]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN067]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN066]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN086]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN065]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN064]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN088]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN063]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN061]


title: HIV Positive with Cervical intraepithelial neoplasia [JCIN060]